Composition
- Active ingredients
- AVIBACTAM SODIUM EQ 0.5GM BASE/VIAL; AZTREONAM 1.5GM/VIAL
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA217906.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Emblaveo
- Active substance
- avibactam sodium
- Route
- Intravenous
- Dosage form
- Powder
- Applicant
- Abbvie
- Status
- Prescription
- FDA approval
- 7 Feb 2025
- Application
- NDA217906-001